BioCentury
ARTICLE | Company News

Oncor, OncorMed deal

October 31, 1994 8:00 AM UTC

The BRUSH1 gene, discovered at the California Pacific Medical Center Research Institute (CPMC) in San Francisco, codes for a putative tumor suppressor gene expressed by breast epithelial cells that appears to be present in 30-50 percent of breast cancers. Doug Dolginow, president and COO of ONCM, said the BRUSH1 gene may be the same gene as BRCA2.

CPMC granted ONCM the exclusive worldwide rights to perform BRUSH1 gene-based diagnostic or evaluative services, and an option for the exclusive worldwide license to any inventions that are developed at CPMC as a result of the collaboration. ...